FORM 8-K

Company

PharmaCyte Biotech, Inc.

Filed

August 26, 2019

Period of Report

August 23, 2019

Accession Number

0001683168-19-002754

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →